A fungal compound has been identified by a team of Chinese researchers as a promising antibiotic candidate, as they presented an approach that can efficiently obtain it the lab, said a study recently published in the journal Nature Communication.
Health organisations across the world are trying to reduce the use of antibiotics. Because the overuse of antibiotics in recent years means they're becoming less effective and has led to the emergence of "superbugs" -- strains of bacteria that have developed resistance to many different types of antibiotics, Xinhua news agency reported.
Meanwhile researchers are working hard to find new antibiotics.
A team, led by researchers at China's Chongqing University, has developed a technique to synthesize albomycins, a group of fungal compounds that have previously shown antimicrobial properties. The authors were able to obtain the substances in large enough amounts to allow them to test their antibiotic activity.
One substance performed well in a test against a variety of bacterial strains. Notably, it outperformed several established antibiotics.
"The method we use can efficiently and conveniently synthesize albomycins substances, and initial animal lab test has demonstrated that these substances are safe, but we will continue our research on its safety," said Yun He, Lead Author of the study.
Further tests are needed to see whether the substance is safe and effective to use as a drug against bacterial infections, according to the team.
--IANS
ksc/ksk
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
